Skip to main content


L'équipe Ad Scientiam est fière de vous annoncer ce nouveau partenariat avec la Société Française de la Mucoviscidose et Vertex Pharmaceuticals

The start-up created in 2013 deploys its solutions using smartphone sensors and algorithms around two axes: support for promoters of clinical trials...

We are looking for men and women 18 to 70 years old with depression to test smartphone application.

Click here for more information

Ad Scientiam accelerates the diffusion of MSCopilot®, the first CE-marked medical device for monitoring multiple sclerosis patients.

Read the article

Despite the deconfinement has begun in France, people with neurological or psychiatric disorders are still at risk from Covid-19. To assist these...

During the unprecedented COVID-19 health crisis, Ad Scientiam ensures the continuity of clinical studies by providing digital solutions for remote...

Ad Scientiam, wants to use artificial intelligence to train a model to predict people's sports preferences. To participate, juste click here and...

The French start-up Ad Scientiam and its platform of digital pathology monitoring tools have already won over many pharmaceutical companies. Launched...

VIDEO Interview of Liouma Tokitsu, Founding President of Ad Scientiam by Astrazeneca and Microsoft AI Factory for Health.


Ad Scientiam has just...

A new partnership has been signed between WeHealth Digital Medicine and Ad Scientiam to develop a mobile health app which integrates physical...

Ad Scientiam and Biogen have entered into a scientific collaboration to develop innovative digital solutions for clinical research in neurosciences....

Video. LIOUMA TOKITSU, President of Ad Scientiam says: "Cet accompagnement avec Pfizer nous a permis d’imaginer de nouveaux moyens de mettre notre...

Watch the video of Liouma Tokitsu, CEO and founder of Ad Scientiam on stage with the CEO of Microsoft, Carlo Purassanta at the

Microsoft Envision The...

Ad Scientiam start-up has been focusing since 2013 on the collection of "valuable" digital biomarkers for clinical research and patient follow-up in...

Pfizer Healthcare Hub France: Liouma Tokitsu interview

creted by Pfizer Healthcare Hub

Interview of Liouma Tokitsu (President and founder of Ad Scientiam) and Sabrina Richeboeuf (Pfizer)

Liouma Tokitsu, CEO and co-founder of Ad Scientiam, was at the Cercle de la Santé show hosted by Jérôme TICHIT on BFM Business. This time the show...

The month of June ended under international spotlights at the 5th European Academy of Neurology Congress at Oslo, where Dr Elisabeth Maillart...

The #MyInvisibleMS” campaign for the 2019 World MS Day aims to alert the general public to the MS invisible symptoms and their impacts on the quality...

On 16th Thursday and 17h Friday our glorious team was at Vivatech, the world’s rendezvous for startups and leaders to celebrate innovation !


Dr Yann le Coz is a medical doctor and a MS patient. As a volunteer he brings his expertise to the development of MSCopilot®. In this video shot by...

Only one month after the ACTRIMS Forum 2019, Ad Scientiam attended the twenty-eighth congress for MS patients and their relatives ! It was organized...

Ad Scientiam among the selected startups for the Microsoft IA factory at Station F


Voir la vidéo



Pfizer has selected Ad Scientiam for its Acceleration Program in the Brain and Spine Institute and Station F.

MSCopilot validation study results will be presented at the ACTRIMS 2019 (Dallas, TX)

Actisleep  study results will be presented at the World Congress of Dermatology 2019 (Milan).



Data on MSCopilot acceptability were presented at the ECTRIMS 2018 (Berlin)

La Depeche published an article about how MSCopilot® can help in MS monitoring.

Read the article

APMnews published an article about the results of the clinical study MSCopilot®

Read the article

TLM published an article about the results of the clinical study MSCopilot®  

Read the article

MSCopilot®, Ad Scientiam's solution for monitoring patients with Multiple Sclerosis, has been clinically compared to Multiple Sclerosis Functional...


Microsoft announces that it has received the Health Data Host (HDS) certification. Thanks to this certification, all healthcare stakeholders will be...

Ad Scientiam annouced today that it has entered into a collaboration with Janssen Pharmaceutica NV to develop a mobile medical application designed to...

Microsoft for Startups offers a unique approach: to connect start-ups benefiting from the program with Microsoft customers and partners

View the...

Dominique Cerutti, CEO of Altran: "A New Paradigm for R&D"

creted by Forbes - 06.11.2018

Altran quotes Ad Scientiam in an article in Forbes magazine on June 11, 2018:

"In health, in France, we have just announced that we will accompany...

This new version of MSCopilot transforms this application into a real dashboard for evaluating and monitoring the patient with multiple sclerosis...

Mobile solution for healthcare professionals / general public monitoring of benign prostatic hypertrophy (BPH). Developed by the start-up Ad...

Ad Scientiam and ifteen other healthcare start-ups have been chosen to receive support in expanding to foreign markets through EIT Health's...

Project partners from Canada have selected eight highly innovative companies to participate in the GoGlobal EIT Health Accelerator Programme in 2018....

Altran accompanies Ad Scientiam on the European compliance of MSCopilot®

Read the press release (in french)



Liouma Tokitsu, Ad Scientiam's CEO, was interviewed at the Paris Healthcare Week.


See the interview (in french)



MSCopilot is evolving and can now be tested before its activation by a Healthcare Professional (in France) ! For the World MS Day 2018, Ad Scientiam...

Liouam Tokitsu, Ad Scientiam CEO, together with Pr. Ayman Tourbah (Neurologist, MS specialist, CHU Reims, France), participated to the CheckUp Sante...

Vivre FM

Saad Zinaï speak about Ad Scientiam in a podcast

Sciences & Avenir

MSCopilot in the spotlight in SCIENCES&AVENIR magazine!

MSCopilot® can now be tested without any code.

François De Berry presents Ad Scientiam

An article about Ad Scientiam in Neurologies

Le Monde Grand Angle published an article about MSCopilot

Ad Scientiam published an article about MSCopilot in revue neurologique

Ad Scientiam was at the First Edition Healthcare data summit Friday, March 23rd 2018.

Read and subscribe to Ad Scientiam's newsletter

En partenariat avec Ad Scientiam, le laboratoire Mylan présente aujourd'hui MyHBP®, une application santé mobile dédiée aux patients souffrant...

Sclérose en plaques : la startup Ad Scientiam, hébergée à l'ICM, révolutionne le parcours de soin du patient avec MSCopilot®

Ad Scientiam présente MSCopilot dans le journal de France Inter : interview de Liouma Tokitsu, Elisabeth Maillart et Yann Le Coz

APMnews: the latest Ad Scientiam software medical device is available on the Google and Apple Stores. It has been developed to improve the monitoring...

Ad Scientiam lance MSCopilot, l'appli pour le suivi de la sclérose en plaques

Ad Scientiam has launched a multi-centric clinical validation study, on 200+ participants, for its multiple sclerosis assessment solution, MSCopilot

An article about Ad Scientiam in "Les Echos"...

Ad Scientiam solution, MSCopilot (Digital self-Assessment for Multiple Sclerosis), was...

2 weeks ago, Ad Scientiam won the 2017 Digital Innovation Competition in the Health category.
It will allow us to access a financing by the Programme...

Liouma Tokitsu, Ad Scientiam CEO, and Alexis Génin, Head of research and technology development at the Brain and Spine Institute, were interviewed by...

The iPEPS, Brain and Spine Institute’s incubator in which we are hosted, becomes Station F unique health partner for the development of new medical...

We are proud to announce that we have been rewarded by BPI France in the Health category of the 6th Edition of the Digital Innovation Competition,...

Driven by the wish to develop relevant and useful mobile applications, Ad Scientiam closely collaborates with patient advocacy groups at every step of...

Ad Scientiam launches its own validation clinical study on 200 patients in 10 Neurology centers specialized in Multiple Sclerosis

Sleep and Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Application and Actigraphy (ACTISLEEP)

Scientific article about Ad Scientiam solution in MS (DAMS)

creted by Dr Mikaël COHEN - Neurologist Hôpital Pasteur, CHU Nice

We are presenting an application under development, dedicated to patients with Mutiple Sclerosis (MS). This solution aims at facilitating patient...

Ad Scientiam Interview in ""

creted by

Find out how Ad Scientiam managed to enter the very exclusive connected health sector

Ad Scientiam invited by ROCHE France at "Hello Tomorrow"

creted by hello_tomorrow

Hello Tomorrow: "Where science and technology meet entrepreneurship to build our tomorrow". Ad Scientiam is invited by Roche France

Data: big, open, smart… How can real-world data impact the lifecycle management of drug products?

A pilot study comparing the MSFC score to the DAM application, a self-assessment solution for MS patients

The French newspaper "L'usine nouvelle" presents Ad Scientiam in the top50 most innovative startups

Article on Ad Scientiam in

creted by

Ad Scientiam is developing medical monitoring 2.0: the startup has developed a solution to collect real-world data for medical research, using the...

A medical application soon reimbursed by French Securite Sociale?

A reference for business angels and other investors, as well as...

The French President, François Hollande, has visited the Brain & Spine Institute during the International Day for University Hopsital Institutes, on...

Softlanding Program in Boston is organised by Medicen Paris Region, French Tech Hub, Bpifrance and MassMedic

Ad Scientiam a le plaisir de vous annoncer que les sessions santé connectée revienne en février.

Ad Scientiam a le plaisir de vous annoncer que les sessions santé connectée reviennent pour une 4ème édition.

Roche France & Ad Scientiam signed a partnership to develop a digital solution on Multiple Sclerosis.

Interview for the website "Acteurs de Santé". Video in French


Humanism and new technologies. Presentation in French by Dr Monteil from Ad Scientiam

Vidéo of the Dr Monteil for "Acteurs de Santé"

Dr Medjebar in the INDUS, a pharma university newspaper

Ad Scientiam at the 11th Women's Global Forum 2015

BFM Business

Dr. Cecile Monteil has been invited to participate to a broadcast on BFM business, concerning the place of technology in health care system's...

Watch the Dr Monteil's presentation about the first french Research kit application.

The French magazine What's up doc present an event organized by Ad Scientiam where the French startup annonces the launch of the first study with...

Ad Scientiam is pleased to announce that the connected health sessions are back.

Ad Scientiam wins the Startup Contest 2015 in the health category

After Top 100, Ad Scientiam is in the Top 30 of the best French startups.

Interview on the French radio about connected health with Dr Monteil from Ad Scientiam

Ad Scientiam is pleased to announce that the connected health sessions are back.

The french newspaper "Le Quotidien du Medecin" interviews us about modernization of medical research

Dr. Monteil from Ad Scientiam presents a debate about connected devices and eHealth during the "e-Santé 2015" Conference

BFM Business

TV broadcast in French about the impact of eHelath on patient-doctor link with Dr Monteil from Ad Scientiam

Ad Scientiam wins the selection and enters in the acceleration program of ALTRAN

BIO Europe Spring

Presentation of Ad Scientiam at ICT for Health during the BIO Europe Spring conference

Ad Scientiam in a French health conference

Osons la France

Cecile Monteil, from Ad Scientiam, has spoken on the topic « mHealth, what can we expect? »

TEDx Compiègne

Dr. Monteil from Ad Scientiam participates to TEDx Talk Compiegne about mHealth

Horizon Pluriel

Horizon Puriel magazine publishes an article about Dr. Cecile Monteil and Dr. Benjamin Pitrat


Ad Scientiam is presented on M6 by Dr. Cecile Monteil and Dr. Benjamin Pitrat

Dr. Cecile Monteil is interviewed by France Inter in a broadcast dedicated to eHealth

Dr. Benjamin Pitrat exposes his vision about patient's insight

How smartphones are used in medical research

Ad Scientiam and ICM are organizing the first information and brainstorming session on this topic, bringing together clinicians and researchers of...

A French TV broadcast (France 24) with Dr Pitrat from Ad Scientiam

An Article by Rue 89 speaks about the Internet of Things and Ad scientiam

Liouma Tokitsu, an alumni of EPITA, Computing Engineering School founded Ad Scientiam...

Ad Scientiam connecte les patients suivis

Les Echos

Article in “Les Echos” speaks about Ad scientiam

Article on the site : The letter of biotechnologies n°4


Article on the site : dmdPost


Article on the site of “L’Express” journal

DIM Brain & Health

Article on the site of scientific networks DIM Brain & Health

Ad Scientiam receives an award on the event “salon des entrepreneurs” (the Show of the Entrepreneur )